et_marketsabout 3 hours ago
NEUTRAL(85%)
hold
Sai Parenteral IPO Day 3: 43% subscribed; here’s a look at GMP and key details; Should you invest?
Read original source+16.5
Market Impact Score
-100 Bearish+100 Bullish
AI Analysis
The broader market is experiencing negative global cues, with Sensex and Nifty opening in the red. This cautious sentiment could impact IPO listings, especially those without strong GMPs.
Trading Insight
Given the subdued broader market and lack of GMP for Sai Parenteral, traders should approach new listings with caution, prioritizing companies with clear listing gains or strong fundamentals for long-term holds.
Quick check: NIFTY neutral, SENSEX neutral.
Key Evidence
- •Sai Parenteral IPO subscribed 43% on Day 3.
- •Strong NII (Non-Institutional Investor) interest but weak retail participation.
- •No GMP (Grey Market Premium) indicates a flat listing.
- •Brokerages recommend subscribing for the long term, citing growth potential in injectables and CDMO segments.
- •Valuations appear at a premium compared to peers.
AI-powered analysis by
Anadi Algo News